A prospective, multicenter phase 2 trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.
Improving evidence-based treatment selection and patient-centered care in upper GI cancers: A Project ECHO initiative. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.
Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose–Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose–Positron Emission Tomography OPTICAL was a randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results